GILEAD SCIENCES, INC.

Q3 2025 13F Detailed Holdings

Location
Foster City, CA
Holdings as of
9/30/2025
Value
$1.79B
Num holdings
9
Date filed
11/13/2025
Form type
13F-HR
Prev filing
8/14/2025
Next filing
2/12/2026
Note
Holdings broken out by “other managers” reported in original SEC filing, see here for holdings aggregated across other managers
Sym Issuer Name Cl CUSIP Value ($000) % Shares Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 Gilead Therapeutics A1 Unlimited Co 028-25083